Achieve Life Sciences ACHV
NASDAQ ACHV
$8.49 +0.18 (+2.17%)
As of: Sep 4, 2026 · 3:59 PM EDT

Achieve Life Sciences (ACHV) Operating Income (2010 - 2012)

Achieve Life Sciences' (ACHV) quarterly Operating Income came in at $8.3 million in Q3 2012, up 102.34% YoY from $4.1 million in Q4 2011, and up 39.47% on a QoQ basis from $5.9 million in Q2 2012.

Analysis

Achieve Life Sciences (ACHV) Operating Income (2010 - 2012) Analysis & Trends

Achieve Life Sciences (ACHV) has 3 years of Operating Income data on file, last reported at $8.3 million in Q3 2012.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 493.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -505.13 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 133.12 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -1.55 Mn
10 Achieve Life Sciences 369.90 Mn 369.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 8.29 Mn
Jun 30, 2012 5.94 Mn
Mar 31, 2012 -5.50 Mn
Sep 30, 2011 4.10 Mn
Jun 30, 2011 4.99 Mn
Mar 31, 2011 -5.23 Mn
Sep 30, 2010 -6.95 Mn
Jun 30, 2010 -2.85 Mn